» Authors » Aaron Li

Aaron Li

Explore the profile of Aaron Li including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 24
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li A, Lou E, Leder K, Foo J
JCO Clin Cancer Inform . 2025 Mar; 9:e2400160. PMID: 40053881
Purpose: Circulating tumor DNA (ctDNA) assays are promising tools for the prediction of cancer treatment response. Here, we build a framework for the design of ctDNA biomarkers of therapy response...
2.
Zhao X, Zhou Y, Kwak W, Li A, Wang S, Dallenger M, et al.
Nat Commun . 2024 Oct; 15(1):8492. PMID: 39353899
The severe mismatch between solid bioelectronics and dynamic biological tissues has posed enduring challenges in the biomonitoring community. Here, we developed a reconfigurable liquid cardiac sensor capable of adapting to...
3.
Wenger E, Martinie R, Ushimaru R, Pollock C, Sil D, Li A, et al.
J Am Chem Soc . 2024 Aug; 146(35):24271-24287. PMID: 39172701
Hyoscyamine 6β-hydroxylase (H6H) is an iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenase that produces the prolifically administered antinausea drug, scopolamine. After its namesake hydroxylation reaction, H6H then couples the newly installed C6...
4.
Li A, Lou E, Leder K, Foo J
bioRxiv . 2024 Jul; PMID: 39005329
Circulating tumor DNA assays are promising tools for the prediction of cancer treatment response. Here, we build a framework for the design of ctDNA biomarkers of therapy response that incorporate...
5.
Wei J, Shao Y, Qiao S, Li A, Hou S, Zhang W
Anal Chem . 2023 Nov; 95(45):16435-16446. PMID: 37921449
Biomolecular characterization is essential in fields such as drug discovery, glycomics, and cell biology. This feature article focuses on the experimental use of quartz crystal microbalance with dissipation (QCM-D) as...
6.
Li A, Kibby D, Foo J
J Math Biol . 2023 Sep; 87(4):59. PMID: 37707631
Tumor recurrence, driven by the evolution of drug resistance is a major barrier to therapeutic success in cancer. Tumor drug resistance is often caused by genetic alterations such as point...
7.
Li A, Kibby D, Foo J
ArXiv . 2023 Jul; PMID: 37396604
Tumor recurrence, driven by the evolution of drug resistance is a major barrier to therapeutic success in cancer. Resistance is often caused by genetic alterations such as point mutation, which...
8.
Perez-Alday E, Li-Pershing Y, Bender A, Hamilton C, Thomas J, Johnson K, et al.
Comput Biol Med . 2018 Nov; 104:127-138. PMID: 30472495
Aim: Our goal was to investigate the effect of a global XYZ median beat construction and the heart vector origin point definition on predictive accuracy of ECG biomarkers of sudden...